Literature DB >> 17998965

Remission of panic disorder with mirtazapine augmentation of paroxetine: a case report.

Zoran Milan Pavlovic1.   

Abstract

Entities:  

Year:  2007        PMID： 17998965      PMCID： PMC2040276          DOI： 10.4088/pcc.v09n0511d

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  6 in total

1.  Mirtazapine in the treatment of panic disorder.

Authors:  Vladimir Carli; Marco Sarchiapone; Giovanni Camardese; Luisa Romano; Sergio DeRisio
Journal:  Arch Gen Psychiatry       Date:  2002-07

2.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

Review 3.  Defining response and remission in anxiety disorders: toward an integrated approach.

Authors:  Borwin Bandelow
Journal:  CNS Spectr       Date:  2006-10       Impact factor: 3.790

4.  Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.

Authors:  Stefano Pallanti; Leonardo Quercioli; Matteo Bruscoli
Journal:  J Clin Psychiatry       Date:  2004-10       Impact factor: 4.384

5.  Mirtazapine in the treatment of panic disorder: an open-label trial.

Authors:  M Sarchiapone; M Amore; S De Risio; V Carli; V Faia; F Poterzio; C Balista; G Camardese; G Ferrari
Journal:  Int Clin Psychopharmacol       Date:  2003-01       Impact factor: 1.659

6.  Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

Authors:  Pinhas N Dannon; Iulian Iancu; Ami Cohen; Katherine Lowengrub; Leon Grunhaus; Moshe Kotler
Journal:  BMC Psychiatry       Date:  2004-06-11       Impact factor: 3.630
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.